Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future PerspectivesDavide Fiore Bavaro, Annalisa Saracino, Alessandra Belati et al.|Antibiotics|2021Cited by 95
Effectiveness of First-Line Therapy with Old and Novel Antibiotics in Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter baumannii: A Real Life, Prospective, Observational, Single-Center StudyLidia Dalfino, Salvatore Grasso, Adriana Mosca et al.|Antibiotics|2023Cited by 32
Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort StudyDavide Fiore Bavaro, Annalisa Saracino, Roberta Papagni et al.|Infectious Diseases and Therapy|2023Cited by 29
Recurrent neurosurgical site infection by extensively drug-resistant <i>P. aeruginosa</i> treated with cefiderocol: a case report and literature reviewDavide Fiore Bavaro, Annalisa Saracino, Federica Romanelli et al.|Scandinavian Journal of Infectious Diseases|2020Cited by 23
A Possible Outbreak by Serratia marcescens: Genetic Relatedness between Clinical and Environmental StrainsGiuseppina Caggiano, Maria Teresa Montagna, Francesco Triggiano et al.|International Journal of Environmental Research and Public Health|2021Cited by 16